Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Pharmacokinetic-pharmacodynamic modeling of benznidazole and its antitrypanosomal activity in a murine model of chronic Chagas disease.
Assmus F. et al, (2025), PLoS Negl Trop Dis, 19
Simplifying medicine dosing for children by harmonising weight bands across therapeutic areas.
Waalewijn H. et al, (2025), The Lancet. Child & adolescent health, 9, 274 - 282
Dose‐Optimization of a Novel Co‐Formulated Triple Combination Antimalarial Therapy: Artemether‐Lumefantrine‐Amodiaquine
Tarning J. et al, (2025), Clinical Pharmacology & Therapeutics
A LC‐MS/MS Assay for Quantification of Amodiaquine and Desethylamodiaquine in Dried Blood Spots on Filter Paper
Kaewkhao N. et al, (2025), International Journal of Analytical Chemistry, 2025
Author Correction: Impact of standard and long-lasting ivermectin formulations in cattle and buffalo on wild Anopheles survival on Sumba Island, Indonesia.
Kobylinski KC. et al, (2025), Scientific reports, 15
Potential interaction between clorsulon and ivermectin for malaria vector control.
Hongsuwong T. et al, (2025), Medical and veterinary entomology
Potential of emodepside for vector-borne disease control.
Khemrattrakool P. et al, (2025), Malaria journal, 24
In‐host modeling of dengue virus and non‐structural protein 1 and the effects of ivermectin in patients with acute dengue fever
Ding J. et al, (2024), CPT: Pharmacometrics & Systems Pharmacology, 13, 2196 - 2209
Inhibition of Giardia duodenalis by isocryptolepine -triazole adducts and derivatives.
Popruk S. et al, (2024), International journal for parasitology. Drugs and drug resistance, 26
Pharmacometric and statistical considerations for dose optimization
Chotsiri P. et al, (2024), CPT: Pharmacometrics & Systems Pharmacology
Impact of standard and long-lasting ivermectin formulations in cattle and buffalo on wild Anopheles survival on Sumba Island, Indonesia.
Kobylinski KC. et al, (2024), Scientific reports, 14
Population pharmacokinetics of amodiaquine and piperaquine in African pregnant women with uncomplicated Plasmodium falciparum infections
Ding J. et al, (2024), CPT: Pharmacometrics & Systems Pharmacology, 13, 1893 - 1903
Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis
Commons RJ. et al, (2024), The Lancet Child & Adolescent Health, 8, 798 - 808
Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials
Chan XHS. et al, (2024), The Lancet Microbe, 101002 - 101002
Author Correction: Ivermectin metabolites reduce Anopheles survival.
Kobylinski KC. et al, (2024), Scientific reports, 14
Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers.
Tarning J. et al, (2024), Malaria journal, 23
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial
Schilling WHK. et al, (2024), PLOS Medicine, 21, e1004428 - e1004428
Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure.
Abla N. et al, (2024), Malaria journal, 23
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)
Wongnak P. et al, (2024), The Lancet Infectious Diseases, 24, 953 - 963